ClariVest Asset Management’s TG Therapeutics TGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $584K | Hold |
32,808
| – | – | 0.06% | 340 |
|
|
2024
Q2 | $584K | Sell |
32,808
-65
| -0.2% | -$1.16K | 0.06% | 340 |
|
|
2024
Q1 | $500K | Buy |
32,873
+35
| +0.1% | +$532 | 0.05% | 358 |
|
|
2023
Q4 | $561K | Sell |
32,838
-42,635
| -56% | -$728K | 0.03% | 351 |
|
|
2023
Q3 | $631K | Buy |
75,473
+14,140
| +23% | +$118K | 0.03% | 318 |
|
|
2023
Q2 | $1.52M | Buy |
61,333
+23,522
| +62% | +$584K | 0.08% | 169 |
|
|
2023
Q1 | $569K | Buy |
+37,811
| New | +$569K | 0.03% | 366 |
|
|
2021
Q3 | – | Sell |
-13,790
| Closed | -$534K | – | 824 |
|
|
2021
Q2 | $534K | Buy |
13,790
+30
| +0.2% | +$1.16K | 0.02% | 422 |
|
|
2021
Q1 | $663K | Buy |
13,760
+869
| +7% | +$41.9K | 0.02% | 362 |
|
|
2020
Q4 | $670K | Buy |
+12,891
| New | +$670K | 0.02% | 331 |
|